Top-News

Syneron Medical News

Keine aktuellen Kursdaten verfügbar
WKN: A0B7YM
ISIN: IL0010909351
US-Symbol: ELOS
Typ: Aktie

Syneron Medical News

17.07.17 - PR Newswire
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company Announces new executive leadership team ...
15.06.17 - PR Newswire
Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners
Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners PR Newswire
17.05.17 - PR Newswire
Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million PR Newswire
10.05.17 - PR Newswire
Syneron Candela Announces End of Go-Shop Period
Syneron Candela Announces End of Go-Shop Period PR Newswire
03.04.17 - PR Newswire
Syneron Candela Announces Agreement to be Acquired by Funds advised by Apax Partners for $11.00/share in Cash, Representing an Approximate Value of $397 Million
Syneron Candela Announces Agreement to be Acquired by Funds advised by Apax Partners for $11.00/share in Cash, Representing an Approximate Value of $397 Million PR Newswire
27.03.17 - PR Newswire
Syneron Candela Announces CE Mark for CO2RE® Intima
Syneron Candela Announces CE Mark for CO2RE® Intima PR Newswire
01.03.17 - PR Newswire
Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual Meeting
Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual Meeting Updates Include CE Mark Approval for ...
13.02.17 - PR Newswire
Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference
Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference PR Newswire
30.01.17 - PR Newswire
Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017
Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017 PR Newswire
11.11.16 - PR Newswire
Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum
Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum PR Newswire
09.11.16 - PR Newswire
Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million Total Revenue Grows 15.3% Year-​Over-Year; Product Revenue Grows 18.6% Year-​Over-Year GAAP Earnings ...
08.11.16 - PR Newswire
Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term Data
Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term Data In Addition, the United States Patent and ...
17.10.16 - PR Newswire
Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 Revenue
Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 Revenue Strengthens Senior Management Team with High Ranking Aesthetic ...
04.08.16 - PR Newswire
Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09
Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 Emerging Products1 Total Revenue Increased 46% Year-​Over-Year; Grew to ...
25.07.16 - PR Newswire
Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength
Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-​Short 785nm Wavelength New ultra-​short 785nm wavelength is first-​of-its-kind in the ...
18.07.16 - PR Newswire
Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction
Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction UltraShape Power provides a 20% increase in Acoustic Energy; Demonstrates ...
18.07.16 - PR Newswire
Syneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016
Syneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016 PR Newswire
19.05.16 - PR Newswire
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million
Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million Emerging Products(1) Total Revenue Increases 34% Non-GAAP EPS of $0.04 PR Newswire
27.04.16 - PR Newswire
Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016
Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016 PR Newswire
31.03.16 - PR Newswire
Syneron Candela Leads Energy Innovation Discussions at 36th Annual ASLMS Conference
Syneron Candela Leads Energy Innovation Discussions at 36th Annual ASLMS Conference Industry-​leading Physicians Present 11 Abstracts Highlighting Performance and Ease-of-...

Newssuche

Videos

newspaper
25.04.24 +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »